Results 211 to 220 of about 8,258 (239)
Some of the next articles are maybe not open access.
CRISPR-Cas9-Mediated Genome Editing in Paenibacillus polymyxa
In recent years, the clustered regularly interspaced palindromic repeats-Cas (CRISPR-Cas) technology has become the method of choice for precision genome editing in many organisms due to its simplicity and efficacy. Multiplex genome editing, point mutations, and large genomic modifications are attractive features of the CRISPR-Cas9 system.Giulia, Ravagnan +2 more
openaire +2 more sources
Required characteristics of Paenibacillus polymyxa JB-0501 as potential probiotic
Archives of Microbiology, 2013The ability of Paenibacillus polymyxa to inhibit the growth of Escherichia coli generic ATCC 25922 (Escherichia coli ATCC 25922) and to adhere to monolayers of the enterocyte-like human cell line Caco-2 was evaluated. P. polymyxa JB-0501 (P. polymyxa JB-0501), found in a livestock feed probiotic supplement, was compared to P.
Karim, Naghmouchi +3 more
openaire +2 more sources
Paenibacillus polymyxa bioactive compounds for agricultural and biotechnological applications
Biocatalysis and Agricultural Biotechnology, 2019Paenibacillus polymyxa is categorized as an endospore-forming bacterium and Gram-positive bacteria, which have innate beneficial properties in modern biotechnology application. P. polymyxa extensively reviewed as plant growth promoting bacteria which directly gave benefit to the plants by improving nitrogen fixation from atmosphere, increase phosphorus
Daud, N. S. +5 more
openaire +2 more sources
Iнженерiя метаболiзму Paenibacillus polymyxa для продуктивного виробництва 2,3-бутандiолу
Problems of Environmental Biotechnology, 2023Метою роботи є огляд нещодавнiх дослiджень генетичних модифiкацiй метаболiзму P. polymyxa для пiдвищення її продуктивностi виробництва 2,3-бутандiолу.
openaire +1 more source
Metabolic engineering of “last-line antibiotic” colistin in Paenibacillus polymyxa
Metabolic EngineeringColistin, also known as polymyxin E, is a lipopeptide antibiotic used to treat infections caused by multidrug-resistant gram-negative bacteria. It is considered a "last-line antibiotic", but its clinical development is hindered by low titer and impurities resulting from the presence of diverse homologs in microbial fermentation.
Nanzhu Chen +5 more
openaire +2 more sources
Comparison of the spores of Paenibacillus polymyxa prepared at different temperatures
Biotechnology Letters, 2012Paenibacillus polymyxa SQR-21, which is antagonistic against Fusarium oxysporum, is used as a biocontrol agent and, when mixed with organic substances for solid fermentation, produces a bioorganic fertilizer. The spores of P. polymyxa prepared at different temperatures were characterized with respect to the dipicolinic acid content, heat resistance ...
Zhenhua, Huo +9 more
openaire +2 more sources
Structure and characterization of an extracellular polysaccharide from Paenibacillus polymyxa 88A
International Journal of Biological MacromoleculesLevan-type polysaccharides, produced by various organisms, are nontoxic, biocompatible, and biodegradable polymers with a wide range of biological activities. They have high potential for use in medicine, cosmetology, and industry. A large amount of levan (41.1 g L-1) was recovered by ethanol precipitation from a liquid nutrient medium of Paenibacillus
Vyacheslav S, Grinev +8 more
openaire +2 more sources
ВЛИЯНИЕ СОСТАВА ПИТАТЕЛЬНОЙ СРЕДЫ НА РОСТ PAENIBACILLUS POLYMYXA
Актуальная биотехнология, 2023openaire +1 more source